LAVA Medtech Acquisition Corp. Warrants
LVACW
LVACW was delisted on the 12th of May, 2023.
29 hedge funds and large institutions have $2.09M invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
800% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 2
123% more funds holding
Funds holding: 13 → 29 (+16)
36% more capital invested
Capital invested by funds: $1.54M → $2.09M (+$555K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$133K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$101K |
| 3 |
GL
Governors Lane
New York
|
+$99.3K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$81.4K |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$283K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$29.2K |
| 3 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$29K |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$4.33K |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
-$974 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCL
26
Glazer Capital LLC
New York
| $5K | +$5.87K | +14,479 | New |
|
27
AllianceBernstein
Nashville,
Tennessee
| $4K | +$5K | +12,347 | New |
|
|
DCM
28
Dupont Capital Management
Wilmington,
Delaware
| $2K | – | – | – |
|
|
AA
29
Ancora Advisors
Cleveland,
Ohio
| $1K | +$690 | +1,704 | New |
|
|
BCM
30
Beryl Capital Management
Redondo Beach,
California
| – | -$283K | -496,499 | Closed |
|
|
FLC
31
Fifth Lane Capital
Austin,
Texas
| – | -$29K | -50,000 | Closed |
|
LVACW Hedge Fund Activity: Q1 2022 in Review
29 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q1 2022, worth a combined $2.09M — up 36% from $1.54M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new LVACW positions and 2 closed out — a net gain of 16 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Saba Capital Management, adding an estimated $133K. The largest seller was Beryl Capital Management, exiting entirely with an estimated $283K sold.
- 29 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q1 2022, up from 13 in Q4 2021.
- Funds reported $2.09M of LAVA Medtech Acquisition Corp. Warrants stock for Q1 2022, up 36% quarter-over-quarter.
- 18 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q1 2022 and 2 closed out, a net change of +16 holders.
- The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q1 2022 was Saba Capital Management, an estimated $133K added.
- The largest LAVA Medtech Acquisition Corp. Warrants seller in Q1 2022 was Beryl Capital Management, an estimated $283K sold.
Based on aggregated 13F filings for Q1 2022.